HealZen Therapeutics and NeuShen Seal Deal for Global Rights to CNS Drug Programs
China-based HealZen Therapeutics has entered into a licensing agreement with compatriot firm NeuShen, focusing on...
AACR 2023 Highlights: CAR-T Therapies and Monoclonal Antibody Combinations in Cancer Research
The 2023 edition of the American Association for Cancer Research (AACR) annual meeting has concluded,...
Hasten Biopharmaceutical Secures $315 Million Investment for Pipeline Expansion
China-based Hasten Biopharmaceutical Co., Ltd has reportedly received USD 315 million in a fundraising round...
Staidson Pharmaceutical Plans RMB 580 Million Private Placement for Drug R&D
China-based Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204) has announced plans to raise RMB 580...
Sangon Biotech Secures RMB 2 Billion in First Financing Round to Boost Life Science Services
China-based contract research organization (CRO) Sangon Biotech has secured RMB 2 billion (USD 290.3 million)...
Shenzhen 01 Life Science Secures RMB 100 Million in Series B1 Financing for Microecology Platform
Shenzhen 01 Life Science and Technology Ltd. Co., Ltd, a company specializing in human big...
Pfizer’s Prevenar 13 Receives Expanded Age Range Approval in China
U.S.-based pharmaceutical giant Pfizer (NYSE: PFE) has reported receiving an additional indication approval from the...
BeiGene’s Tislelizumab-Chemo Combo Excels in RATIONALE 305 Trial for Gastric Cancer
BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235), a China-based biopharmaceutical company, has announced that the...
Zylox-Tonbridge Medical Teams Up with Hicicare Science for Guide Wire Product Sales in China
China-based nerve and peripheral vascular interventional device developer Zylox-Tonbridge Medical Technology (HKG: 2190) has announced...
Shanghai Ark Biopharmaceutical’s STAR Market IPO Filing Accepted, Aims to Raise $289.6 Million
Shanghai Ark Biopharmaceutical Co., Ltd’s Initial Public Offering (IPO) filing to the Shanghai Stock Exchange’s...
Hunan Warrant Pharmaceutical Receives NMPA Approval for Generic Brivudine
Hunan Warrant Pharmaceutical Co., Ltd (SHA: 688799), a China-based pharmaceutical company, has announced receiving marketing...
Junshi Biosciences’ Tuoyi Combo Shows Promise in Phase III Neotorch Study for NSCLC
China-based Junshi Biosciences (HKG: 1877, SHA: 688180) has published the results of the Phase III...
Jiangsu Aidea Pharmaceutical Secures Global Licensing Deal for Kainos Medicine’s HIV Drugs
Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488), a China-based pharmaceutical company, has entered into a...
Acotec Scientific’s Vericor-14 Microcatheter Receives NMPA Approval for Vascular Surgeries
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
Janssen’s Spravato Approved by NMPA for Adult Depression and Suicidal Ideation Treatment
Janssen’s Spravato (esketamine) has been granted approval by the National Medical Products Administration (NMPA) in...
Jiangxi Jemincare Group Secures Clinical Trial Approvals for Four Innovative Drugs
Jiangxi Jemincare Group, a China-based pharmaceutical company, has announced receiving clinical trial approvals for four...
CSPC Pharmaceutical Group Gets NMPA Approval for SYS6010 ADC Clinical Trial
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received clinical trial...
Legend Biotech’s Carvykti Data Boosts Stock Price by 19.64% on Positive Phase III Results
Shares of Legend Biotech (NASDAQ: LEGN) jumped an impressive 19.64% in a single day, attributed...
Acotec Scientific Holdings Receives NMPA Approval for Paclitaxel-Coated Balloon Dilation Catheter
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
CARSgen Therapeutics’ CT041 Receives NMPA Approval for Post-Operative Pancreatic Cancer Therapy
China-based chimeric antigen receptor (CAR)-T cell specialist, CARSgen Therapeutics Holdings Ltd (HKG: 2171), has announced...